- Trials with a EudraCT protocol (5)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (1)
5 result(s) found for: Gd2.
Displaying page 1 of 1.
EudraCT Number: 2022-003812-98 | Sponsor Protocol Number: BUTTERFLY | Start Date*: 2023-04-04 | |||||||||||
Sponsor Name:Institute of Mother and Child | |||||||||||||
Full Title: To evaluate the efficacy and safety of naxitamab in patients with refractory Ewing's sarcoma. | |||||||||||||
Medical condition: Ewing's sarcoma | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: PL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-015936-14 | Sponsor Protocol Number: CH14.181021 | Start Date*: 2010-03-10 | |||||||||||
Sponsor Name:University Children´s Hospital Tübingen, | |||||||||||||
Full Title: PHASE II FEASIBILITY STUDY USING CH14.18/CHO ANTIBODY AND SUBCUTANEOUS INTERLEUKIN 2 AFTER HAPLOIDENTICAL STEM CELL TRANSPLANTATION IN CHILDREN WITH RELAPSED NEUROBLASTOMA | |||||||||||||
Medical condition: Pediatric patients with relapsed neuroblastoma | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: AT (Completed) DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2021-004729-55 | Sponsor Protocol Number: GD2CAR02 | Start Date*: 2023-07-14 | |||||||||||
Sponsor Name:IRCCS, OSPEDALE PEDIATRICO BAMBINO GESÙ DI ROMA | |||||||||||||
Full Title: Phase I study of anti-GD2 Chimeric Antigen Receptor-Expressing T cells in pediatric and young adult patients affected by relapsed/refractory central nervous system tumors | |||||||||||||
Medical condition: Relapsed/refractory malignant central nervous system tumors | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Children, Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-002475-26 | Sponsor Protocol Number: GD2CAR01 | Start Date*: 2017-12-22 | |||||||||||
Sponsor Name:IRCCS Ospedale Pediatrico Bambino Gesù | |||||||||||||
Full Title: Phase I/II study of anti-GD2 Chimeric Antigen Receptor-Expressing T cells in pediatric patients affected by High Risk and/or relapsed/refractory Neuroblastoma | |||||||||||||
Medical condition: High Risk and/or relapsed/refractory Neuroblastoma | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-001489-17 | Sponsor Protocol Number: SIOPENRNET003 | Start Date*: 2006-11-17 |
Sponsor Name:St. Anna Kinderkrebsforschung e.V. | ||
Full Title: High Risk Neuroblastoma Study 1 of SIOP-Europe (SIOPEN) | ||
Medical condition: High Risk Neuroblastoma | ||
Disease: | ||
Population Age: Infants and toddlers, Children, Adolescents, Under 18, Adults | Gender: Male, Female | |
Trial protocol: AT (Ongoing) ES (Restarted) GB (GB - no longer in EU/EEA) BE (Ongoing) DK (Restarted) IE (Ongoing) HU (Ongoing) FI (Ongoing) SI (Completed) PL (Ongoing) GR (Ongoing) | ||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.